Legal status by country
Is Angiotensin II legal?
Written by Aaron CuhaReviewed Sep 2026
How Angiotensin II is classified in the United States, United Kingdom, Australia and Canada, side by side. Each country has its own page with a direct answer, the regulator's approval status and what the classification means in practice.
All four countries, side by side
| Attribute | United States · FDA | United Kingdom · MHRA | Australia · TGA | Canada · Health Canada |
|---|---|---|---|---|
| Status | Approved | Not approved | Not approved | Not approved |
| Classification | FDA-approved, prescription only | Prescription only; check current MHRA status | Prescription only; check current TGA status | Prescription only; check current Health Canada status |
| Note | GIAPREZA, NDA 209360, approved 21 December 2017; on the 11 September 2026 Drugs@FDA query two presentations were Prescription and one was Discontinued, and a generic was approved in June 2025. | None recorded | None recorded | None recorded |
US FDA status: FDA approved 21 December 2017 (GIAPREZA, NDA 209360) to increase blood pressure in adults with septic or other distributive shock. Prescription only, intravenous. A generic angiotensin II acetate injection was approved 3 June 2025 (ANDA 216966).. Reviewed Sep 2026.
Related compounds
General information current as of Sep 2026, not legal advice. Classifications change; confirm with the regulator or a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships.